School of Medicine

Ronald C. Rubenstein, MD, PhD, a highly regarded physician-scientist with expertise in cystic fibrosis, has been named director of the Division of Allergy and Pulmonary Medicine in the Department of Pediatrics at the School of Medicine. He began his new position Sept. 1.

School of Medicine researchers have discovered that a molecule produced by the immune system acts on the brain to change the behavior of mice. The findings help illuminate a surprising mind-body connection.

Older people without cognitive problems who experience a fall may have undetected neurodegeneration in their brains that puts them at high risk of developing Alzheimer’s dementia, according to a study from Washington University School of Medicine.

School of Medicine scientists have created a PET imaging agent that detects signs of inflammation. Such a tracer could aid diagnosis and study of diseases ranging from cardiovascular disease to cancer to COVID-19.

Washington University’s Deanna Barch was among 59 women psychologists working in academia who took an empirical approach to understanding gender inequities in their field. They find some promising data, but also much work to be done.

Robert W. Gereau IV, the Dr. Seymour and Rose T. Brown Professor and vice chair for research in the Department of Anesthesiology at the School of Medicine, has received the Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH).

The Healthcare Innovation Lab and the School of Medicine’s Institute for Informatics are holding a Big Ideas competition aimed at innovations in informatics and health-care delivery focused on COVID-19. The deadline is Sept. 30.

Washington University School of Medicine in St. Louis is the clinical coordinating center for an international trial aimed at evaluating on a large scale whether the MMR vaccine can protect front-line health-care workers against COVID-19.

Transplant surgeons and researchers at Washington University School of Medicine in St. Louis have received two grants totaling $10 million from the National Institutes of Health (NIH) to study how immune cells contribute to organ rejection, with the aim of improving the viability of organs after transplant.

The Department of Emergency Medicine at the School of Medicine has opened a telemedicine health clinic for employees and dependents ages 18 and older who suffer from minor ailments and acute illnesses.